Grant: Discovery Grants Program - Individual
University of Calgary
$55,000.00
Modeling Entamoeba histolytica host-parasite interactions
FY 2021-22
Summary
Background: Entamoeba histolytica (Eh) is a protozoan parasite that harmlessly colonizes the colonic mucus layer and feed on bacteria in 99% of infection. However when mucosal barriers are weakened, Eh invades the colon and triggers a robust host pro-inflammatory response with high levels of TNF-a and IL-1ß in innate host defense. Direct contact of live Eh with immune cells elicits a response that is different in both magnitude and quality compared to responses elicited by released Eh components. Only Eh in direct contact with macrophages activate the NLRP3 inflammasome in a Gal-lectin and Eh cysteine protease 5 (EhCP-A5) dependent manner. Gal-lectin forms a bridge between Eh and macrophages allowing engagement of Eh surface cysteine proteinase EhCP-A5 RGD motif to ligate a5ß1 integrin to trigger ATP release for the activation of caspase-1 dependent NLRP3 inflammasome. Eh also induce caspase-4 activation that enhanced the cleavage of caspase-1 CARD domains and both caspase acted together to cleave gasdermin D (GSDMD), liberating the N-terminal p30 pore-forming fragment for the release of bioactive IL-1ß without significant cell death. Although the NLRP3 inflammasome and caspase-1/4 activation cause elevated levels of IL-1ß release we still do not understand how large-scale pro-inflammatory responses are initiated upon Eh contact with macrophage in innate host defense against invasion. This crucial gap in our knowledge is key to understanding how Eh remains a harmless colonizer and/or invader in the gut where it is controlled by innate host responses. Research Aims and Approach: Over the next five years I will address three complementary aims: (1) To determine the subunits of caspase-1/4 that interact with one another to increase caspase-1 IL-1ß bioactivity. This will be done by identifying the subunits of caspase-1 CARD domains that are cleaved by activated caspase-1 by LC-MS/MS sequencing and by transfecting predicted caspase-1 cleavage sites with caspase-1 and IL-1ß in COS7 cells followed by stimulation with Eh. (2) To investigate the mechanism of caspase-4 activation in Eh-stimulated macrophages. To do this we will first determine if caspase-4 requires a two-signal model for activation and to identify the caspase-4 intermediate forms by LC-MS/MS with enzymatic activity. (3) To quantify what role GSDMD plays in Eh-induced intestinal inflammation. This will be achieved by infecting Gsdmd+/+ and Gsdmd-/- littermates in the colon and quantifying Eh-induced pro-inflammatory responses and cell death by caspase-3 cleavage and TUNEL assay. Significance: This work will define the mechanisms of how inflammatory caspase-4/1 activation through a contact-dependent signaling synapse between Eh and host immune cells deciphers Eh invasion versus colonized Eh to distinguish the severity of infection and tune immune responses appropriately.
Program
Discovery Grants Program - Individual
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2019-04136
Name nom
Chadee, Khrisendath
Department département
Microbiology and Infectious Diseases - Microbiology and Infectious Diseases
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2019
Award amount
55000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5203
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Protozoology
Research subject fr
Protozoologie
Installment
inst:3
Partie
1
Nb partie
5
Application title
Modeling Entamoeba histolytica host-parasite interactions
Keyword
NSERC
Application summary
Background: Entamoeba histolytica (Eh) is a protozoan parasite that harmlessly colonizes the colonic mucus layer and feed on bacteria in 99% of infection. However when mucosal barriers are weakened, Eh invades the colon and triggers a robust host pro-inflammatory response with high levels of TNF-a and IL-1ß in innate host defense. Direct contact of live Eh with immune cells elicits a response that is different in both magnitude and quality compared to responses elicited by released Eh components. Only Eh in direct contact with macrophages activate the NLRP3 inflammasome in a Gal-lectin and Eh cysteine protease 5 (EhCP-A5) dependent manner. Gal-lectin forms a bridge between Eh and macrophages allowing engagement of Eh surface cysteine proteinase EhCP-A5 RGD motif to ligate a5ß1 integrin to trigger ATP release for the activation of caspase-1 dependent NLRP3 inflammasome. Eh also induce caspase-4 activation that enhanced the cleavage of caspase-1 CARD domains and both caspase acted together to cleave gasdermin D (GSDMD), liberating the N-terminal p30 pore-forming fragment for the release of bioactive IL-1ß without significant cell death. Although the NLRP3 inflammasome and caspase-1/4 activation cause elevated levels of IL-1ß release we still do not understand how large-scale pro-inflammatory responses are initiated upon Eh contact with macrophage in innate host defense against invasion. This crucial gap in our knowledge is key to understanding how Eh remains a harmless colonizer and/or invader in the gut where it is controlled by innate host responses. Research Aims and Approach: Over the next five years I will address three complementary aims: (1) To determine the subunits of caspase-1/4 that interact with one another to increase caspase-1 IL-1ß bioactivity. This will be done by identifying the subunits of caspase-1 CARD domains that are cleaved by activated caspase-1 by LC-MS/MS sequencing and by transfecting predicted caspase-1 cleavage sites with caspase-1 and IL-1ß in COS7 cells followed by stimulation with Eh. (2) To investigate the mechanism of caspase-4 activation in Eh-stimulated macrophages. To do this we will first determine if caspase-4 requires a two-signal model for activation and to identify the caspase-4 intermediate forms by LC-MS/MS with enzymatic activity. (3) To quantify what role GSDMD plays in Eh-induced intestinal inflammation. This will be achieved by infecting Gsdmd+/+ and Gsdmd-/- littermates in the colon and quantifying Eh-induced pro-inflammatory responses and cell death by caspase-3 cleavage and TUNEL assay. Significance: This work will define the mechanisms of how inflammatory caspase-4/1 activation through a contact-dependent signaling synapse between Eh and host immune cells deciphers Eh invasion versus colonized Eh to distinguish the severity of infection and tune immune responses appropriately.